Table 1.
Outcome Measures From the Fifth Postoperative Day Comparing the Results Between the Animals That Underwent Experimental Glaucoma-Filtering Surgery with the Insertion of Implants That Contain Bevacizumab or Did Not Contain Bevacizumab
| Groups | IOP difference (mmHg)a | Bleb area (central)b | Bleb area (maximum)b | Bleb highb | Vascularizationb |
|---|---|---|---|---|---|
| PUI | 1.1±1.0 | 2.0±0.1 | 3.0±0.1 | 2.0±0.1 | 3.0±0.1 |
| BPUI | 2.9±0.8 | 2.0±0.4 | 3.0±0.3 | 3.0±0.4 | 3.0±0.1 |
| P value | 0.413 | 0.72 | 0.72 | 0.057 | 0.72 |
a
IOP difference=postoperative IOP (on day 5) −preoperative IOP, expressed as mean±SE.
b
Scores were based on the Moorfields Bleb Grading System, were expressed as medians±SE, and were analyzed with a Wilcoxon signed-rank test.
PUI, polyurethane implant; BPUI, bevacizumab-loaded polyurethane implant; IOP, intraocular pressure; SE, standard errors.